Rapid Readout: Expert Perspectives on Multiple Sclerosis - Data from the 8th Joint ACTRIMS-ECTRIMS Meeting 2020

home / news-network / rapid-readout-expert-perspectives-multiple-sclerosis-2020-joint-actrims-ectrims

Experts in multiple sclerosis review top data presented at the 8th joint ACTRIMS-ECTRIMS meeting.

Ofatumumab vs Teriflunomide: ASCLEPIOS I/II RMS Trials

EP. 1: Ofatumumab vs Teriflunomide: ASCLEPIOS I/II RMS Trials

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
OLKIOS: Looking at Ofatumumab’s Continued Efficacy

EP. 2: OLKIOS: Looking at Ofatumumab’s Continued Efficacy

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
OPTIMUM: Ponesimod Superiority in MRI-based Outcomes in RRMS

EP. 3: OPTIMUM: Ponesimod Superiority in MRI-based Outcomes in RRMS

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
Rationale for Selected Dosing Regimen of Evobrutinib in Phase 3 Studies

EP. 4: Rationale for Selected Dosing Regimen of Evobrutinib in Phase 3 Studies

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
Takeaways From ACTRIMS-ECTRIMS 2020 Meeting

EP. 5: Takeaways From ACTRIMS-ECTRIMS 2020 Meeting

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
Phase 3 ASCLEPIOS I/II Open-Label Extension Study: Ofatumumab vs Teriflunomide

EP. 6: Phase 3 ASCLEPIOS I/II Open-Label Extension Study: Ofatumumab vs Teriflunomide

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
OLKIOS Phase 3b Trial: Pivotal Endpoints and Potential Significance

EP. 7: OLKIOS Phase 3b Trial: Pivotal Endpoints and Potential Significance

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
OPTIMUM Phase 3 Trial: Ponesimod’s Cardiac Safety Data

EP. 8: OPTIMUM Phase 3 Trial: Ponesimod’s Cardiac Safety Data

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
Ozanimod Compared to Teriflunomide Utilizing Statistical Matching

EP. 9: Ozanimod Compared to Teriflunomide Utilizing Statistical Matching

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
Key Takeaways from the 8th ACTRIMS-ECTRIMS 2020 Meeting

EP. 10: Key Takeaways from the 8th ACTRIMS-ECTRIMS 2020 Meeting

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
Ofatumumab vs Teriflunomide: Phase 3 ASCLEPIOS I/II Open-Label Extension Study

EP. 11: Ofatumumab vs Teriflunomide: Phase 3 ASCLEPIOS I/II Open-Label Extension Study

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
Chief Endpoints and Potential Significance: Phase 3b OLIKOS Trial

EP. 12: Chief Endpoints and Potential Significance: Phase 3b OLIKOS Trial

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
CLARITY Extension Trial: Disability Improvement With Cladribine

EP. 13: CLARITY Extension Trial: Disability Improvement With Cladribine

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
COVID-19 in MS Global Data-Sharing Initiative Anti-CD20 Therapy Results

EP. 14: COVID-19 in MS Global Data-Sharing Initiative Anti-CD20 Therapy Results

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
Impact of Results From the COVID-19 in MS Global Data-Sharing Initiative

EP. 15: Impact of Results From the COVID-19 in MS Global Data-Sharing Initiative

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC;Robert Naismith, MD;Bianca Weinstock-Guttman, MD
November 24th 2020
Video
© 2024 MJH Life Sciences

All rights reserved.